These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 23414321)

  • 1. Analysis of promoter non-CG methylation in prostate cancer.
    Truong M; Yang B; Wagner J; Desotelle J; Jarrard DF
    Epigenomics; 2013 Feb; 5(1):65-71. PubMed ID: 23414321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CpG island hypermethylation frequently silences FILIP1L isoform 2 expression in prostate cancer.
    Desotelle J; Truong M; Ewald J; Weeratunga P; Yang B; Huang W; Jarrard D
    J Urol; 2013 Jan; 189(1):329-35. PubMed ID: 23174249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of Filamin A interacting protein 1-like is associated with promoter methylation and induces an invasive phenotype in ovarian cancer.
    Burton ER; Gaffar A; Lee SJ; Adeshuko F; Whitney KD; Chung JY; Hewitt SM; Huang GS; Goldberg GL; Libutti SK; Kwon M
    Mol Cancer Res; 2011 Aug; 9(8):1126-38. PubMed ID: 21693594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrence.
    Truong M; Yang B; Wagner J; Kobayashi Y; Rajamanickam V; Brooks J; Jarrard DF
    Br J Cancer; 2012 Jun; 107(1):100-7. PubMed ID: 22596233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation mediated silencing of TMS1/ASC gene in prostate cancer.
    Das PM; Ramachandran K; Vanwert J; Ferdinand L; Gopisetty G; Reis IM; Singal R
    Mol Cancer; 2006 Jul; 5():28. PubMed ID: 16848908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asymmetric methylation in the hypermethylated CpG promoter region of the human L1 retrotransposon.
    Woodcock DM; Lawler CB; Linsenmeyer ME; Doherty JP; Warren WD
    J Biol Chem; 1997 Mar; 272(12):7810-6. PubMed ID: 9065445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
    Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
    Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate cancer epigenomics.
    Perry AS
    J Urol; 2013 Jan; 189(1):10-1. PubMed ID: 23063895
    [No Abstract]   [Full Text] [Related]  

  • 11. Global methylation pattern of genes in androgen-sensitive and androgen-independent prostate cancer cells.
    Mishra DK; Chen Z; Wu Y; Sarkissyan M; Koeffler HP; Vadgama JV
    Mol Cancer Ther; 2010 Jan; 9(1):33-45. PubMed ID: 20053773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azacytidine and decitabine induce gene-specific and non-random DNA demethylation in human cancer cell lines.
    Hagemann S; Heil O; Lyko F; Brueckner B
    PLoS One; 2011 Mar; 6(3):e17388. PubMed ID: 21408221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the unique methylation pattern of androgen receptor (AR) promoter in prostate stem/progenitor cells with 5-aza-2'-deoxycytidine (5-AZA) leads to suppressed prostate tumorigenesis.
    Tian J; Lee SO; Liang L; Luo J; Huang CK; Li L; Niu Y; Chang C
    J Biol Chem; 2012 Nov; 287(47):39954-66. PubMed ID: 23012352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of novel hypermethylated genes in prostate cancer using genomic CpG island microarrays.
    Kron K; Pethe V; Briollais L; Sadikovic B; Ozcelik H; Sunderji A; Venkateswaran V; Pinthus J; Fleshner N; van der Kwast T; Bapat B
    PLoS One; 2009; 4(3):e4830. PubMed ID: 19283074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia.
    Devaney JM; Wang S; Funda S; Long J; Taghipour DJ; Tbaishat R; Furbert-Harris P; Ittmann M; Kwabi-Addo B
    Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):292-300. PubMed ID: 23896626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue.
    Geybels MS; Zhao S; Wong CJ; Bibikova M; Klotzle B; Wu M; Ostrander EA; Fan JB; Feng Z; Stanford JL
    Prostate; 2015 Dec; 75(16):1941-50. PubMed ID: 26383847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG hypermethylation of MDR1 gene contributes to the pathogenesis and progression of human prostate cancer.
    Enokida H; Shiina H; Igawa M; Ogishima T; Kawakami T; Bassett WW; Anast JW; Li LC; Urakami S; Terashima M; Verma M; Kawahara M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Cancer Res; 2004 Sep; 64(17):5956-62. PubMed ID: 15342374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promoter CpG-Site Methylation of the KAI1 Metastasis Suppressor Gene Contributes to Its Epigenetic Repression in Prostate Cancer.
    Lee J; Lee MS; Jeoung DI; Kim YM; Lee H
    Prostate; 2017 Mar; 77(4):350-360. PubMed ID: 27813113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG methylation at promoter site -140 inactivates TGFbeta2 receptor gene in prostate cancer.
    Zhao H; Shiina H; Greene KL; Li LC; Tanaka Y; Kishi H; Igawa M; Kane CJ; Carroll P; Dahiya R
    Cancer; 2005 Jul; 104(1):44-52. PubMed ID: 15895377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylation of the gamma-catenin gene is associated with poor prognosis of renal cell carcinoma.
    Breault JE; Shiina H; Igawa M; Ribeiro-Filho LA; Deguchi M; Enokida H; Urakami S; Terashima M; Nakagawa M; Kane CJ; Carroll PR; Dahiya R
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):557-64. PubMed ID: 15701841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.